Pharmasum Therapeutics has received support from the highly competitive Regional Research Fund for the project “A novel drug for treating dementia in Down syndrome” READ MORE >>

Pharmasum Therapeutics presented at the annual DNB Healthcare Venture session READ MORE >>

Pharmasum Therapeutics announces the publication of an article titled “Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome” in the journal Pharmaceuticals. READ MORE >>